TIRVA ROBERT L. (Interim CFO) sold 0.6% of their position (6.42K shares) of DNA X, INC. on the open market
Open‑market sale worth $4.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2021ACC: 0000899243-21-035919
-6.42K
Net shares
Net seller
$4.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.42K
Price / share
$0.67
Trade value
$4.30K
% of position
0.6%
9/10/2021
1.05M→1.04M
Total
Net shares
−6.42K
Net value
-$4.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2021 | S · Sale | −6.42K | $0.67 | $4.30K | 0.6% | 1.05M | 1.04M |
| Total | −6.42K | -$4.30K | ||||||
Derivative Transactions0
No derivative transactions reported